Abiopharma

News list

Director Skovronsky Daniel 🟡 adjusted position in 0 shares of MYRIAD GENETICS INC (MYGN) Transaction Date: Jun 23, 2026 | Filing ID: 044911

Full text

News bot June 23, 2026, 8:48 p.m.
🔍 Skovronsky Daniel (Director)

Company: MYRIAD GENETICS INC (MYGN)

Report Date: 2026-06-23
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 1
- Total shares held: 195,507
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-23 | Code: H | shares_owned_after: 195,507.00
Footnotes:
- REMARKS: This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as a director of the Company, effective June 17, 2026, and therefore is no longer subject to Section 16 reporting.